Zhigang Cheng

Zhigang Cheng

Auto-generated profile, based on publicly available information

Zhigang Cheng

Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, People's Republic of China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2013 in International Journal of Hyperthermia
Verified
Journal Article
Open access
DZDezhi Zhang
Dezhi Zhang
PLPing Liang
Ping Liang
XYXiaoling Yu
Xiaoling Yu
ZCZhigang Cheng
Zhigang Cheng
ZHZhiyu Han
Zhiyu Han
FLFangyi Liu
Fangyi Liu
Purpose: The aim of this study was to evaluate the feasibility, safety, and efficiency of percutaneous microwave ablation (MWA) with artificial pleural effusion for liver tumours located in the hepatic dome. Materials and methods: A total of 112 sessions of artificial pleural effusion performed on 102 liver tumour patients were summarised and analysed at our hospital. Among them, 31 hepatocellular carcinoma patients treated by percutaneous MWA were selected as the artificial pleural effusion group. The control group without artificial pleural effusion was matched with tumour size, tumour location and the histological grades of differentiation. The primary technique effectiveness rate, local tumour progression rate and tumour-free survival rate were compared. Results: Artificial pleural effusion was achieved successfully in 110 of 112 sessions (98.2%), which helped to improve the visibility in 98.8% (82/83) and acquire safe puncture path in 96.3% (26/27). There were no statistical differences between the artificial pleural effusion group and the control group in the primary technique effectiveness rate (p = 1.000), the 1-, 2-, and 3-year local tumour progression rates (p = 0.669), and the 1-, 2-, and 3-year tumour-free survival rates (p = 0.979). Conclusions: Percutaneous MWA with artificial pleural effusion could be a feasible, safe, and effective technique for liver tumours located in the hepatic dome.

1 March 2024 in Radiology
Verified
Journal Article
Closed access
FLFangyi Liu
Fangyi Liu
MBMingsen Bi
Mingsen Bi
XJXiang Jing
Xiang Jing
HDHong Ding
Hong Ding
JZJie Zeng
Jie Zeng
PLPing Liang
Ping Liang
A multiparametric US predictive model combining attenuation coefficient, alanine aminotransferase level, and international normalized ratio showed good ability to predict metabolic dysfunction–asso... Background Noninvasive evaluation of metabolic dysfunction–associated fatty liver disease (MAFLD) with multiparametric US is essential, but multicenter studies are lacking. Purpose To evaluate the ...

28 July 2022 in Journal of Hepatocellular Carcinoma
Verified
Journal Article
Open access
PDF file
CAChao An
Chao An
HYHongcai Yang
Hongcai Yang
XYXiaoling Yu
Xiaoling Yu
ZHZhi-Yu Han
Zhi-Yu Han
ZCZhigang Cheng
Zhigang Cheng
PLPing Liang
Ping Liang
Background and Aim: Early recurrence (ER) presents a challenge for the survival prognosis of patients with hepatocellular carcinoma (HCC). The aim of this study was to investigate machine learning (ML) models using clinical data for predicting ER after microwave ablation (MWA). Methods: Between August 2005 and December 2019, 1574 patients with early-stage HCC underwent MWA at four hospitals were reviewed. Then, 36 clinical data points per patient were collected, and the patients were assigned to the training, internal, and external validation set. Apart from traditional logistic regression (LR), three ML models—random forest, support vector machine, and eXtreme Gradient Boosting (XGBoost)—were built and validated for their predictive ability with the area under ROC curve (AUC). Algorithms such as SHapley Additive exPlanations (SHAP) and local interpretable model-agnostic explanations (LIME) were used to realize their interpretability. Results: The three ML models all outperformed LR (P < 0.001 for all) in predictive ability. When nine variables (tumor number, platelet, α-fetoprotein, comorbidity score, white blood cell, cholinesterase, prothrombin time, neutrophils, and etiology) were extracted simultaneously using recursive feature elimination with cross-validation, the XGBoost model achieved the best discrimination among all models, with an AUC value 0.75 (95% CI [confidence interval]: 0.72– 0.78) in the training set, 0.74 (95% CI: 0.69– 0.80) in the internal validation set, and 0.76 (95% CI: 0.70– 0.82) in the external validation set, and it was interpreted depending on the visualization of risk factors by the SHAP and LIME algorithms. The predictive system of post-ablation recurrence risk stratification was provided on online (http://114.251.235.51:8001/) based on XGboost analysis. Conclusion: The XGBoost model based on clinical data can effectively predict ER risk after MWA, which can contribute to surveillance, prevention, and treatment strategies for HCC.


1 February 2019 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
CAChao An
Chao An
XLXin Li
Xin Li
PLPing Liang
Ping Liang
JYJie Yu
Jie Yu
ZCZhigang Cheng
Zhigang Cheng
LDLinan Dong
Linan Dong
Purpose: This study aimed to investigate the clinical value of a tumor map for assessing the ablative effect after ultrasound-guided percutaneous microwave ablation (US-PMWA) for hepatocellular carcinoma (HCC). Methods: The medical records of 68 patients (49 male and 19 female, 59.9±12.7 years) with HCC who underwent US-PMWA from May 2013 to May 2017 were reviewed. A tumor map was generated from the fusion of three-dimensional (3D) visualization images based on the preoperative target tumor and postoperative ablation area, to evaluate whether the ablation area covering the tumor has reached a 5 mm ablative margin (AM). The lesions were divided into two groups according to the tumor maps: group A (failed to achieve AM) and group B (achieved AM). The cumulative local tumor progression (LTP) rates of both groups were statistically analyzed using the log-rank test. Results: Success rate of tumor map generation was 100% (68/68), and no residual tumors were found. MWA-related 3D images, which included target tumor volume, ablation area volume, and residual liver ratio, were compared between groups A and B (P=0.295, P=0.772, and P=0.527, respectively). Technique effectiveness rate (91.7% vs 100%) was achieved in the two groups, showing no significant statistical differences (P=0.672). The 3-, 6-, 9-, and 12-month LTP rate was 8.3%, 16.7%, 20.8%, and 34%, respectively, for group A and 0%, 2.8%, 2.8%, and 2.8%, respectively, for group B, showing significant statistical differences (P<0.001) between the two groups. Conclusion: The novel technology of tumor map generated from 3D visualization of image fusion is feasible and useful in evaluating the ablative effect of US-PMWA for HCC.

6 March 2019 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
ZCZhigang Cheng
Zhigang Cheng
PLPing Liang
Ping Liang
Diagnostic and Interventional Radiology